ZHENG Jianjun. Value on detection of high-risk human papilloma virus, squamous cell carcinoma antigen and squamous cell associated carcinoma antigen after radical resection of cervical cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(23): 58-60. DOI: 10.7619/jcmp.201923017
Citation: ZHENG Jianjun. Value on detection of high-risk human papilloma virus, squamous cell carcinoma antigen and squamous cell associated carcinoma antigen after radical resection of cervical cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(23): 58-60. DOI: 10.7619/jcmp.201923017

Value on detection of high-risk human papilloma virus, squamous cell carcinoma antigen and squamous cell associated carcinoma antigen after radical resection of cervical cancer

  •   Objective  To study the value of high-risk human papilloma virus (HR-HPV), squamous cell carcinoma antigen (SCC-Ag) and squamous cell carcinoma associated antigen (SCCA) levels after radical operation of cervical cancer.
      Methods  A total of 50 patients with cervical cancer were selected as study subjects, and were followed up every 3 months within 1 to 2 years and every 6 months within 2 to 5 years after surgery. During follow-up, HR-HPV, SCC-Ag and SCCA levels of patients were detected, and their value in prediction of recurrence was explored.
      Results  The positive rates of HR-HPV and SCC-Ag in 5 recurrence patients after operation were significantly higher than those without recurrence (P < 0.05). The positive rate of serum SCCA in recurrence patients was significantly higher than those without recurrence(P < 0.05).
      Conclusion  The combined detection of HR-HPV, SCC-Ag and SCCA after radical resection of cervical cancer is of great value in assistant diagnosis, curative effect evaluation and prognosis monitoring of cervical cancer.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return